Results 211 to 220 of about 813,932 (302)
AMETHYST: A Retrospective Cohort Study of Treatment Patterns and Outcomes in Patients With Glucocorticoid‐Refractory Macrophage Activation Syndrome Complicating Still's Disease
Arthritis &Rheumatology, EarlyView.Objective
Information is limited on the natural history and current treatment patterns in macrophage activation syndrome (MAS), a life‐threatening hyperinflammatory syndrome complicating Still's disease (systemic juvenile idiopathic arthritis [sJIA] and adult‐onset Still's disease [AOSD]).Alexei Grom, Jordi Antón, Edward M. Behrens, Corey Best, Norbert Blank, Josefin Blomkvist, Scott W. Canna, Sonia Carriquí, Shanmuganathan Chandrakasan, Andrew Danquah, Ngoc‐Bao Duong, Brian D. Jamieson, Paivi Miettunen, Abiola Oladapo, Sampath Prahalad, Pierre Quartier, Grant Schulert, Anna Stoltenberg, Uwe Ullmann, Erika Van Nieuwenhove, Sebastiaan J. Vastert, Fabrizio De Benedetti +21 morewiley +1 more sourceHigher risk of Long COVID among patients with autoimmune rheumatic diseases and immunomodulatory therapy: a retrospective cohort analysis of national US data.
Arthritis &Rheumatology, Accepted Article.Background
Little is known about the prevalence of and factors associated with Long COVID in patients with autoimmune rheumatic diseases (AIRDs). Methods
We conducted a retrospective cohort study using data from the National Clinical Cohort Collaborative (N3C).Namrata Singh, A. Jerrod Anzalone, Holland Stevenson, Londyn Robinson, Lesley E. Jackson, Sandra E. Safo, Zachary Butzin‐Dozier, Kaleb Michaud, Maria I. Danila, Jasvinder A. Singh, Rena C. Patel, on behalf of the National Clinical Cohort Collaborative (N3C) Consortium +11 morewiley +1 more sourceInitial Treatment Strategies and Outcomes Across Hemodynamic Thresholds and Risk Stratification in Incident Systemic Sclerosis–Associated Pulmonary Arterial Hypertension: A EUSTAR Analysis
Arthritis &Rheumatology, EarlyView.Objective
Real‐world initial treatment strategies in systemic sclerosis–associated pulmonary arterial hypertension (SSc‐PAH) remain incompletely described. We aimed to characterize these strategies across hemodynamic thresholds and risk strata and evaluate outcome associations. Methods
We analyzed treatment‐naive patients with SSc‐PAH from the European Hilde Jenssen Bjørkekjær, Cosimo Bruni, Kaspar Broch, Cathrine Brunborg, Patricia E. Carreira, Paolo Airò, Carmen Pilar Simeón‐Aznar, Marie‐Elise Truchetet, Alessandro Giollo, Alexandra Balbir‐Gurman, Mickael Martin, Christopher P. Denton, Armando Gabrielli, Francesco Del Galdo, Madelon C. Vonk, Håvard Fretheim, Helle Bitter, Øyvind Midtvedt, Arne K. Andreassen, Sverre Høie, Yoshiya Tanaka, Gabriela Riemekasten, Ulf Müller‐Ladner, Marco Matucci‐Cerinic, Ivan Castellví, Elise Siegert, Eric Hachulla, Øyvind Molberg, Oliver Distler, Anna‐Maria Hoffmann‐Vold, on behalf of the European Scleroderma Trials and Research (EUSTAR) collaborators, Serena Guiducci, Florenzo Iannone, Simona Rednic, Yannick Allanore, Carlomaurizio Montecucco, Gábor Kumánovics, Michele Iudici, Gianluca Moroncini, Kristofer Andréasson, Luca Idolazzi, Jörg Henes, Johannes Pflugfelder, José António Pereira da Silva, Michael Hughes, Valeria Riccieri, Andra Balanescu, Ana Maria Gheorghiu, Christina Bergmann, Francesco Paolo Cantatore, Ellen De Langhe, Branimir Ani, Carolina de Souza Müller, Kamal Solanki, Edoardo Rosato, Britta Maurer, Lesley Ann Saketkoo, Massimiliano Limonta, Vivien M. Hsu, Lorinda S Chung, Yair Levy, Petros Sfikakis, Susana Oliveira, Masataka Kuwana +63 morewiley +1 more sourceRisk-adapted HLA delisting and imlifidase-enabled deceased-donor kidney transplantation in highly sensitized kidney transplant candidates: a German expert consensus report. [PDF]
Front ImmunolReuter S, Benning L, Dick A, Dilz LM, Einecke G, Emmerich F, Grahammer F, Großmann R, Gwinner W, Halleck F, Hallensleben M, Heinemann FM, Jänigen B, Kannenkeril D, Kauke T, Kelsch R, Kemmner S, Kluger MA, Kowald J, Kribben A, Lehmann C, Lindemann M, Maccagno G, Morath C, Mühlfeld A, Pham L, Renders L, Schaub S, Scherer S, Seidl C, Spriewald B, Stippel D, Stumpf J, Tran TH, Weimer R, Wilde B, Zecher D, Ziemann M, Ziganshyna S, Lachmann N, Budde K. +40 moreeuropepmc +1 more sourceDifferentiation and Pathologic Significance of Tissue‐Resident Memory‐Like CD8+ T Cells in Systemic Lupus Erythematosus
Arthritis &Rheumatology, EarlyView.Objective
Tissue‐resident memory T (TRM) cells have been implicated in organ‐specific immune pathology; however, the pathologic relevance of TRM‐like CD8+ T cells in systemic lupus erythematosus (SLE) remains unclear. We investigated their differentiation mechanisms and pathologic significance in SLE, including associations with disease activity and ...Yuya Fujita, Kaoru Yamagata, Satoshi Kubo, Ippei Miyagawa, Koshiro Sonomoto, Yurie Satoh‐Kanda, Masanobu Ueno, Shumpei Kosaka, Aya Nawata, Yoshiya Tanaka, Shingo Nakayamada +10 morewiley +1 more source